Study Stopped
Recruiting or enrolling participants has halted prematurely and will not resume.
Attenuation Corrected Cardiac SPECT Using the GE Hawkeye Camera System
Hawkeye
1 other identifier
interventional
608
1 country
1
Brief Summary
The accuracy of stress single photon emission computed tomography (SPECT) is limited by imaging artifacts, many of which are caused by soft tissue attenuation. A recent multicenter study performed by our laboratory comparing 7 commercially available attenuation correction (AC) camera systems in a cardiac phantom showed the best performance with the GE Hawkeye (a hybrid gamma camera-CT scanner) and the University of Michigan M-step (unique feature a camera orbit of 360˚ versus the usual 180˚) systems. In this study we will combine the strengths of these two systems (GE Hawkeye AC system and 360˚ camera orbit) to test the accuracy of this imaging system in a population of 400 consecutive patients undergoing clinically indicated stress SPECT. These patients will undergo SPECT imaging both with conventional methodology and the GE Hawkeye system. The conventional study will be interpreted and reported in the usual clinical fashion. The GE Hawkeye images will be interpreted independently by 2 observers blinded to the results of conventional imaging and will not be reported clinically. The primary study hypothesis is that AC will substantially reduce attenuation artifacts (mild fixed defects) without reducing the accuracy of either normal studies or myocardial infarction (MI). Clinical data and noninvasive test results (history of MI, electrocardiogram, and gated wall motion) will be used to distinguish defects which represent attenuation (false-positive) versus those due to MI (true-positive).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Jul 2001
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2001
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2004
CompletedFirst Submitted
Initial submission to the registry
December 21, 2007
CompletedFirst Posted
Study publicly available on registry
January 7, 2008
CompletedApril 23, 2015
April 1, 2015
3.1 years
December 21, 2007
April 21, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The overall comparisons of the agreement between conventional SPECT imaging and the GE Hawkeye system will be completed using McNemar's test.
Measured/Compared at time of each scan.
Secondary Outcomes (1)
Comparisons of categorical factors between the 2 tests will also be completed using McNemar's test, continuous factors will be completed using a paired t-test if the differences are normally distributed.
Measured/Compared at time of study
Study Arms (1)
Clinical SPECT
ACTIVE COMPARATORGE Hawkeye Attenuation Correction Camera is being compared to the approved clinical use SPECT camera.
Interventions
GE Hawkeye AC system and 360˚ camera orbit
Eligibility Criteria
You may qualify if:
- Patients referred to the Charlton Nuclear Cardiology Laboratory for stress Tc-99m sestamibi SPECT
You may not qualify if:
- Prior PTCA or CABG
- Left bundle branch block (LBBB) or paced ventricular rhythm
- Clinically significant valvular heart disease
- Hypertrophic or idiopathic dilated cardiomyopathy
- Atrial fibrillation or frequent atrial or ventricular ectopy (defined as \>20% ectopic beats
- History of MI
- ECG evidence of MI
- Chest circumference \>55 inches
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic
Rochester, Minnesota, 55905, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Todd D Miller, MD
Mayo Clinic
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 21, 2007
First Posted
January 7, 2008
Study Start
July 1, 2001
Primary Completion
August 1, 2004
Study Completion
August 1, 2004
Last Updated
April 23, 2015
Record last verified: 2015-04